AMY GALLAWAY: Open Payments
NPI 1609129980 · MIDDLETOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 27 payments from 13 companies in 2025. Trend: 2023 $199 · 2024 $234 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 7 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $49 |
| Seqirus USA Inc | 2 | $41 |
| Dexcom, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $33 |
| ABBVIE INC. | 2 | $30 |
| Tactile Systems Technology Inc | 1 | $29 |
| Medtronic, Inc. | 1 | $25 |
Products named: VOQUEZNA, Dexcom G6 Transmitter, Veozah, LAGEVRIO, Flexitouch Plus, Wegovy, MINIMED 780G, BREZTRI.
Industry payments across MD — which companies pay providers there.
